The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.
Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.
The top stories from the 2018 ASCO annual meeting: overexcited coverage of cancer blood tests and how a gene test can tailor breast cancer treatment.
Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier.
Category: Science blog November 8, 2017
In our round-up of this year’s NCRI conference we reveal exciting new research that’s helping scientists get to know cancer better.
Category: Science blog June 19, 2017
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report.
We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.
At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.